 Vanadate hyperglycemia mouse models non-insulin-dependent diabetes mellitus effects oral administration vanadate insulinometic agent potent inhibitor phosphotyrosyl protein phosphatase PTPase vitro blood glucose PTPase action hyperinsulinemic rodent models non-insulin-dependent diabetes NIDDM Oral administration vanadate mg/ml drinking water mice wk blood glucose level mg/dl effect body weight Administration vanadate mice similar effect Electron microscopic examination signs hepatotoxicity treatment slight reduction insulin receptor autophosphorylation antiphosphotyrosine antibody vivo stimulation phosphorylation endogenous substrate insulin receptor ob/ob mice cytosolic particulate PTPase activities liver ob/ob mice dephosphorylation peptide major site insulin receptor autophosphorylation db/db diabetic mice PTPase activity cytosolic fraction control values significant difference particulate PTPase activity Treatment vanadate hepatic PTPase activity vitro receptor substrate phosphorylation vivo ob/ob mice substantial effect blood glucose data vanadate effective oral hypoglycemic treatment NIDDM states major effects distal insulin receptor tyrosine kinase